BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, Rosenwasser LJ, Roufosse F, Gleich GJ, Klion AD. Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol 2010;126:45-9. [PMID: 20639008 DOI: 10.1016/j.jaci.2010.03.042] [Cited by in Crossref: 198] [Cited by in F6Publishing: 148] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Faverio P, Bonaiti G, Bini F, Vaghi A, Pesci A. Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy. Ther Clin Risk Manag 2018;14:2385-96. [PMID: 30573961 DOI: 10.2147/TCRM.S159949] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Armoni Domany K, Shiran SI, Adir D, Lavie M, Levin D, Diamant N, Gut G, Benor S. The Effect of Mepolizumab on the Lungs in a Boy with Hypereosinophilic Syndrome. Am J Respir Crit Care Med 2020;202:e34-5. [DOI: 10.1164/rccm.201907-1376im] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Valent P, Gleich GJ, Reiter A, Roufosse F, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, Sotlar K, Butterfield JH, Cerny-Reiterer S, Mayerhofer M, Vandenberghe P, Haferlach T, Bochner BS, Gotlib J, Horny HP, Simon HU, Klion AD. Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field. Expert Rev Hematol 2012;5:157-76. [PMID: 22475285 DOI: 10.1586/ehm.11.81] [Cited by in Crossref: 98] [Cited by in F6Publishing: 82] [Article Influence: 9.8] [Reference Citation Analysis]
4 Kanda A, Yun Y, Bui DV, Nguyen LM, Kobayashi Y, Suzuki K, Mitani A, Sawada S, Hamada S, Asako M, Iwai H. The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions. Allergol Int 2021;70:9-18. [PMID: 33243693 DOI: 10.1016/j.alit.2020.11.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
5 Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J. Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol. 2012;130:563-571. [PMID: 22935585 DOI: 10.1016/j.jaci.2012.07.027] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
6 Wieser JK, Kuehn GJ, Prezzano JC, Cusick EH, Stiegler JD, Scott GA, Liesveld JL, Beck LA. Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment. JAAD Case Rep 2020;6:292-5. [PMID: 32258301 DOI: 10.1016/j.jdcr.2020.02.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Williams KW, Ware J, Abiodun A, Holland-Thomas NC, Khoury P, Klion AD. Hypereosinophilia in Children and Adults: A Retrospective Comparison. J Allergy Clin Immunol Pract 2016;4:941-947.e1. [PMID: 27130711 DOI: 10.1016/j.jaip.2016.03.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
8 Lammel V, Stoeckle C, Padberg B, Zweifel R, Kienle DL, Reinhart WH, Simon HU. Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung. Lung Cancer. 2012;76:493-495. [PMID: 22420949 DOI: 10.1016/j.lungcan.2012.02.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
9 Heinig B, Vojvocic A, Lotti T, Tirant M, Wollina U. Wells Syndrome - An Odyssey. Open Access Maced J Med Sci 2019;7:3002-5. [PMID: 31850109 DOI: 10.3889/oamjms.2019.572] [Reference Citation Analysis]
10 Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol. 2010;126:39-44. [PMID: 20538328 DOI: 10.1016/j.jaci.2010.04.011] [Cited by in Crossref: 142] [Cited by in F6Publishing: 116] [Article Influence: 11.8] [Reference Citation Analysis]
11 Sekkach Y, Mekouar F, Jira M, Elqatni M, Elomri N, Fatihi J, Badaoui M, Hammi S, Smaali J, El Khattabi A, Amezyane T, Abouzahir A, Ghafir D. [Durable efficacity and remission after treatment with imatinib mesylate for FIP1L1-PDGFRA transcript negative associated eosinophilic cardiomyopathy]. Ann Pharm Fr 2011;69:277-81. [PMID: 21924129 DOI: 10.1016/j.pharma.2011.07.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Okuyama S, Satomi H, Ishikawa R, Shishido T, Sato K, Ueki T, Sumi M, Kobayashi H. Eosinophilic Fasciitis with Hypereosinophilia as the Initial Clinical Manifestation of Peripheral T-Cell Lymphoma, Not Otherwise Specified. Intern Med . [DOI: 10.2169/internalmedicine.9300-21] [Reference Citation Analysis]
13 Kanno T, Fukumoto T, Hamada T. Eosinophilic vasculitis as a manifestation of idiopathic hypereosinophilic syndrome. J Dermatol 2021. [PMID: 34927273 DOI: 10.1111/1346-8138.16279] [Reference Citation Analysis]
14 Knutsen AP, Temprano J, Wooldridge JL, Bhatla D, Slavin RG. Environmental Exposures in the Normal Host. Kendig & Chernick’s Disorders of the Respiratory Tract in Children. Elsevier; 2012. pp. 858-76. [DOI: 10.1016/b978-1-4377-1984-0.00059-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Valent P, Klion AD, Rosenwasser LJ, Arock M, Bochner BS, Butterfield JH, Gotlib J, Haferlach T, Hellmann A, Horny HP, Leiferman KM, Metzgeroth G, Matsumoto K, Reiter A, Roufosse F, Rothenberg ME, Simon HU, Sotlar K, Vandenberghe P, Weller PF, Gleich GJ. ICON: Eosinophil Disorders. World Allergy Organ J 2012;5:174-81. [PMID: 23282419 DOI: 10.1097/WOX.0b013e31827f4192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
16 Park SM, Park JW, Kim SM, Koo EH, Lee JY, Lee CS, Choi DC, Lee BJ. A case of hypereosinophilic syndrome presenting with multiorgan infarctions associated with disseminated intravascular coagulation. Allergy Asthma Immunol Res 2012;4:161-4. [PMID: 22548210 DOI: 10.4168/aair.2012.4.3.161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Sandhya P, Danda D, Mathew J, Kurian S, Ramakrishna BS. Eosinophilic esophagitis and pharyngitis presenting as mass lesion in a patient with inactive rheumatoid arthritis. J Clin Rheumatol. 2012;18:33-35. [PMID: 22157269 DOI: 10.1097/rhu.0b013e31823e6b54] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
18 Lim KS, Ko J, Lee SS, Shin B, Choi DC, Lee BJ. A case of idiopathic hypereosinophilic syndrome presenting with acute respiratory distress syndrome. Allergy Asthma Immunol Res 2014;6:98-101. [PMID: 24404401 DOI: 10.4168/aair.2014.6.1.98] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Marvisi C, Sinico RA, Salvarani C, Jayne D, Prisco D, Terrier B, Emmi G, Vaglio A; the European EGPA Study Group. New perspectives in eosinophilic granulomatosis with polyangiitis (EGPA): report of the first meeting of the European EGPA Study Group. Intern Emerg Med 2019;14:1193-7. [DOI: 10.1007/s11739-019-02166-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Stahl M, Mohareb AM, Lee AI, Federman DG, Siddon AJ, Spelman J. Multi-system complications of hypereosinophilia. Am J Hematol 2016;91:444-7. [PMID: 26700720 DOI: 10.1002/ajh.24283] [Reference Citation Analysis]
21 Patel B, Butterfield JH, Weiler CR, Kane SV. Tolerance and Efficacy with Simultaneous Use of Two Monoclonal Antibodies for a Patient with Hypereosinophilic Syndrome and Ulcerative Colitis. Monoclon Antib Immunodiagn Immunother 2016;35:300-3. [PMID: 27911676 DOI: 10.1089/mab.2016.0038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Abo Shdid R, Azrieh B, Alebbi S, Mansour S, Naeem M. Idiopathic Hypereosinophilic Syndrome with Multiple Organ Involvement. Case Rep Oncol 2021;14:249-55. [PMID: 33776712 DOI: 10.1159/000511396] [Reference Citation Analysis]
23 Jung JM, Lee MH, Won CH, Chang SE, Lee MW, Choi JH, Moon KC. A Case of Focal Eosinophilic Myositis Associated with Hypereosinophilic Syndrome: A Rare Case Report. Ann Dermatol 2015;27:629-30. [PMID: 26512186 DOI: 10.5021/ad.2015.27.5.629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
24 Wu EY, Hernandez ML, Jennette JC, Falk RJ. Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review. J Allergy Clin Immunol Pract 2018;6:1496-504. [PMID: 30197069 DOI: 10.1016/j.jaip.2018.07.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
25 Desai N, Morkhandikar S, Sahay R, Jijina F, Patil P. Myeloproliferative hypereosinophilic syndrome presenting as cardiac failure and response to imatinib. Am J Ther 2014;21:e35-7. [PMID: 24603276 DOI: 10.1097/MJT.0b013e3182491df1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Klion AD. Eosinophilic myeloproliferative disorders. Hematology Am Soc Hematol Educ Program 2011;2011:257-63. [PMID: 22160043 DOI: 10.1182/asheducation-2011.1.257] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
27 Vaglio A, Buzio C, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy 2013;68:261-73. [PMID: 23330816 DOI: 10.1111/all.12088] [Cited by in Crossref: 148] [Cited by in F6Publishing: 107] [Article Influence: 16.4] [Reference Citation Analysis]
28 Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, Haahtela T, Lambrecht BN, Postma DS, Sunyer J, Valenta R, Akdis CA, Annesi-Maesano I, Arno A, Bachert C, Ballester F, Basagana X, Baumgartner U, Bindslev-Jensen C, Brunekreef B, Carlsen KH, Chatzi L, Crameri R, Eveno E, Forastiere F, Garcia-Aymerich J, Guerra S, Hammad H, Heinrich J, Hirsch D, Jacquemin B, Kauffmann F, Kerkhof M, Kogevinas M, Koppelman GH, Kowalski ML, Lau S, Lodrup-Carlsen KC, Lopez-Botet M, Lotvall J, Lupinek C, Maier D, Makela MJ, Martinez FD, Mestres J, Momas I, Nawijn MC, Neubauer A, Oddie S, Palkonen S, Pin I, Pison C, Rancé F, Reitamo S, Rial-Sebbag E, Salapatas M, Siroux V, Smagghe D, Torrent M, Toskala E, van Cauwenberge P, van Oosterhout AJ, Varraso R, von Hertzen L, Wickman M, Wijmenga C, Worm M, Wright J, Zuberbier T. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011;66:596-604. [PMID: 21261657 DOI: 10.1111/j.1398-9995.2010.02534.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 108] [Article Influence: 11.0] [Reference Citation Analysis]
29 Cogan E, Roufosse F. Clinical management of the hypereosinophilic syndromes. Expert Rev Hematol 2012;5:275-89; quiz 290. [PMID: 22780208 DOI: 10.1586/ehm.12.14] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
30 Zemleduch T, Czapla A, Kimla P, Kudliński B, Craig TJ. Rare Case of a Young Male Presented with Abdominal Pain, Solid Colon Tumors, and Eosinophilia, Followed by Tremendous Thromboembolic Complications and Eventually Diagnosed with Idiopathic Hypereosinophilic Syndrome. Case Reports in Medicine 2022;2022:1-5. [DOI: 10.1155/2022/1424749] [Reference Citation Analysis]
31 Matsuno O, Minamoto S. Retropharyngeal edema: A rare manifestation of eosinophilic granulomatosis with polyangiitis. Respir Med Case Rep 2021;34:101539. [PMID: 34745873 DOI: 10.1016/j.rmcr.2021.101539] [Reference Citation Analysis]
32 Amini-Vaughan ZJ, Martinez-Moczygemba M, Huston DP. Therapeutic strategies for harnessing human eosinophils in allergic inflammation, hypereosinophilic disorders, and cancer. Curr Allergy Asthma Rep 2012;12:402-12. [PMID: 22875242 DOI: 10.1007/s11882-012-0290-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
33 Rosenberg J, Aamodt W, Takvorian S, Mullen M. Clinical Reasoning: A young woman with symmetric weakness and behavioral disturbance. Neurology 2018;90:e1442-7. [PMID: 29661906 DOI: 10.1212/WNL.0000000000005335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Herrero B, de la Fuente JR, Aleo E, Carceller F, Lassaletta Á, Orellana MR, Pérez-Martínez A. Spontaneous resolution of hypereosinophilic syndrome in an infant without treatment. J Pediatr Hematol Oncol 2012;34:450-2. [PMID: 22510769 DOI: 10.1097/MPH.0b013e318249579b] [Reference Citation Analysis]
35 Strati P, Cortes J, Faderl S, Kantarjian H, Verstovsek S. Long-term follow-up of patients with hypereosinophilic syndrome treated with Alemtuzumab, an anti-CD52 antibody. Clin Lymphoma Myeloma Leuk 2013;13:287-91. [PMID: 23123105 DOI: 10.1016/j.clml.2012.09.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
36 Salomon G, Severino M, Casassa E, Livideanu CB, Meyer N, Lamant L, Tournier E, Paul C. Skin manifestations of hypereosinophilic syndrome are polymorphous and difficult to treat: A retrospective cohort study. Ann Dermatol Venereol 2022:S0151-9638(21)00110-1. [PMID: 35115205 DOI: 10.1016/j.annder.2021.12.002] [Reference Citation Analysis]
37 Moalong KMC, Diestro JDB, Espiritu AI, Lucero JAC, de la Cruz APRL, Valencia JM, Chua EM 3rd, Cenina ARF, Spears J, San Jose MCZ. FIP1L1-PDGFRA-Positive Hypereosinophilia Presenting with Bilateral Extracranial Carotid Artery Aneurysms. World Neurosurg 2020;139:419-22. [PMID: 32360918 DOI: 10.1016/j.wneu.2020.04.119] [Reference Citation Analysis]
38 Merlotto MR, Cantadori LO, Sakabe D, Miot HA. Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome. An Bras Dermatol 2018;93:451-3. [PMID: 29924226 DOI: 10.1590/abd1806-4841.20187419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Leru PM. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Clin Transl Allergy 2019;9:36. [PMID: 31367340 DOI: 10.1186/s13601-019-0277-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
40 Pillar N, Halkin A, Aviram G. Hypereosinophilic Syndrome With Cardiac Involvement: Early Diagnosis by Cardiac Magnetic Resonance Imaging. Canadian Journal of Cardiology 2012;28:515.e11-3. [DOI: 10.1016/j.cjca.2012.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
41 Ishii K, Mizuuchi T, Yamamoto Y, Mori H, Tago M, Kato E, Hayashi H, Tahara K, Sawada T. Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome. Intern Med 2020;59:1323-30. [PMID: 32101832 DOI: 10.2169/internalmedicine.3707-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Fanouriakis A, Kougkas N, Vassilopoulos D, Fragouli E, Repa A, Sidiropoulos P. Rituximab for eosinophilic granulomatosis with polyangiitis with severe vasculitic neuropathy: Case report and review of current clinical evidence. Semin Arthritis Rheum 2015;45:60-6. [PMID: 25908179 DOI: 10.1016/j.semarthrit.2015.03.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
43 Yamamoto M, Ikuta K, Toki Y, Hatayama M, Shindo M, Torimoto Y, Okumura T. Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report. Medicine (Baltimore) 2017;96:e8001. [PMID: 28885361 DOI: 10.1097/MD.0000000000008001] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
44 Wardlaw AJ, Myers B, Rathbone BJ, Siddiqui S, Wurm P. Unexplained peripheral blood eosinophilia with gastrointestinal symptoms. Clin Exp Allergy 2021;51:623-6. [DOI: 10.1111/cea.13849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Terrier B, Bièche I, Maisonobe T, Laurendeau I, Rosenzwajg M, Kahn JE, Diemert MC, Musset L, Vidaud M, Sène D, Costedoat-Chalumeau N, Le Thi-Huong D, Amoura Z, Klatzmann D, Cacoub P, Saadoun D. Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome. Blood 2010;116:4523-31. [PMID: 20729468 DOI: 10.1182/blood-2010-02-267542] [Cited by in Crossref: 89] [Cited by in F6Publishing: 71] [Article Influence: 7.4] [Reference Citation Analysis]
46 Butterfield JH. Successful Long-Term Control of the Syndrome of Episodic Angioedema With Eosinophilia (Gleich Syndrome) With Low-Dose Imatinib Mesylate and Prednisone. J Investig Med High Impact Case Rep 2021;9:2324709620987691. [PMID: 33459036 DOI: 10.1177/2324709620987691] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Kiani R, Naghavi B, Amin A, Sadeghpour A, Zahedmehr A, Firouzi A, Pouraliakbar HR, Ebrahimi Meymand S, Marashizadeh A, Almasi S. Central Nervous System and Cardiac Involvement in the Hypereosinophilic Syndrome: A Case Report. Immunol Invest 2021;50:356-62. [PMID: 32718188 DOI: 10.1080/08820139.2020.1758131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Langlois AL, Shehwaro N, Rondet C, Benbrik Y, Maloum K, Gueutin V, Rouvier P, Izzedine H. Renal thrombotic microangiopathy and FIP1L1/PDGFRα-associated myeloproliferative variant of hypereosinophilic syndrome. Clin Kidney J 2013;6:418-20. [PMID: 27293571 DOI: 10.1093/ckj/sft067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 McBrien CN, Menzies-Gow A. The Biology of Eosinophils and Their Role in Asthma. Front Med (Lausanne) 2017;4:93. [PMID: 28713812 DOI: 10.3389/fmed.2017.00093] [Cited by in Crossref: 120] [Cited by in F6Publishing: 116] [Article Influence: 24.0] [Reference Citation Analysis]
50 Wang H, Erban JK. Rapid Change in Mental Status in a Patient with Hypereosinophilia. Case Rep Hematol 2017;2017:6936709. [PMID: 28168065 DOI: 10.1155/2017/6936709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 de Graauw E, Beltraminelli H, Simon HU, Simon D. Eosinophilia in Dermatologic Disorders. Immunol Allergy Clin North Am 2015;35:545-60. [PMID: 26209899 DOI: 10.1016/j.iac.2015.05.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
52 Lee MXW, Teng GG, Raju GC, Lim AYN. Catastrophic subarachnoid hemorrhage in eosinophilic granulomatosis with polyangiitis without asthma. Int J Rheum Dis 2017;20:2127-31. [PMID: 25959920 DOI: 10.1111/1756-185X.12594] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Burris D, Rosenberg CE, Schwartz JT, Zhang Y, Eby MD, Abonia JP, Fulkerson PC. Pediatric Hypereosinophilia: Characteristics, Clinical Manifestations, and Diagnoses. J Allergy Clin Immunol Pract 2019;7:2750-2758.e2. [PMID: 31128377 DOI: 10.1016/j.jaip.2019.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
54 Bleeker JS, Syed FF, Cooper LT, Weiler CR, Tefferi A, Pardanani A. Treatment-refractory idiopathic hypereosinophilic syndrome: pitfalls and progress with use of novel drugs. Am J Hematol 2012;87:703-6. [PMID: 22367886 DOI: 10.1002/ajh.23120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
55 Rosenstein RK, Panush RS, Kramer N, Rosenstein ED. Hypereosinophilia and seroconversion of rheumatoid arthritis. Clin Rheumatol 2014;33:1685-8. [PMID: 24609760 DOI: 10.1007/s10067-014-2566-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
56 Roehrl MH, Alexander MP, Hammond SB, Ruzinova M, Wang JY, O'Hara CJ. Eosinophilic myocarditis in hypereosinophilic syndrome. Am J Hematol 2011;86:607-8. [PMID: 21681785 DOI: 10.1002/ajh.21943] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
57 Valent P, Horny HP, Bochner BS, Haferlach T, Reiter A. Controversies and open questions in the definitions and classification of the hypereosinophilic syndromes and eosinophilic leukemias. Semin Hematol 2012;49:171-81. [PMID: 22449627 DOI: 10.1053/j.seminhematol.2012.01.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
58 Klion A. Hypereosinophilic syndrome: approach to treatment in the era of precision medicine. Hematology Am Soc Hematol Educ Program 2018;2018:326-31. [PMID: 30504328 DOI: 10.1182/asheducation-2018.1.326] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
59 Bochner BS, Book W, Busse WW, Butterfield J, Furuta GT, Gleich GJ, Klion AD, Lee JJ, Leiferman KM, Minnicozzi M, Moqbel R, Rothenberg ME, Schwartz LB, Simon HU, Wechsler ME, Weller PF. Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD). J Allergy Clin Immunol 2012;130:587-96. [PMID: 22935587 DOI: 10.1016/j.jaci.2012.07.024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
60 Schwarz C, Müller T, Lau S, Parasher K, Staab D, Wahn U. Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood. Pediatr Allergy Immunol 2018;29:28-33. [PMID: 28986919 DOI: 10.1111/pai.12809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
61 Butterfield J, Weiler C. Treatment of Hypereosinophilic Syndromes—The First 100 Years. Seminars in Hematology 2012;49:182-91. [DOI: 10.1053/j.seminhematol.2012.01.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
62 Basso JR, Bizinoto LGZ, Limone GA, Enokihara MMSS, Espirito-Santo Filho KD, Fonseca AR, Agondi RC, Gois AFT, Cunha LL. Episodic angioedema with eosinophilia (Gleich's syndrome) associated with urticarial vasculitis: a coincidence or a novel clinical entity? Braz J Med Biol Res 2021;54:e10745. [PMID: 33886812 DOI: 10.1590/1414-431X202010745] [Reference Citation Analysis]
63 Podjasek JC, Butterfield JH. Mortality in hypereosinophilic syndrome: 19 years of experience at Mayo Clinic with a review of the literature. Leukemia Research 2013;37:392-5. [DOI: 10.1016/j.leukres.2012.12.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
64 Farahi N, Loutsios C, Tregay N, Wright AKA, Berair R, Lok LSC, Gillett D, Cullum I, Simmonds RP, Summers C, Wong A, Solanki CK, Buscombe J, Pang PH, Thavakumar A, Peters AM, Brightling CE, Condliffe AM, Chilvers ER. In vivo imaging reveals increased eosinophil uptake in the lungs of obese asthmatic patients. J Allergy Clin Immunol 2018;142:1659-1662.e8. [PMID: 30071200 DOI: 10.1016/j.jaci.2018.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
65 Radonjic-Hoesli S, Valent P, Klion AD, Wechsler ME, Simon HU. Novel targeted therapies for eosinophil-associated diseases and allergy. Annu Rev Pharmacol Toxicol 2015;55:633-56. [PMID: 25340931 DOI: 10.1146/annurev-pharmtox-010814-124407] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
66 Simon HU, Klion A. Therapeutic approaches to patients with hypereosinophilic syndromes. Semin Hematol 2012;49:160-70. [PMID: 22449626 DOI: 10.1053/j.seminhematol.2012.01.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
67 Kyabonaki JJ, Nørgaard BL, Høyer S, Andersen NH. Hypereosinophilic Syndrome Leading to Severe Right-Sided Heart Failure in a Patient with Ebstein's Anomaly. Case Rep Cardiol 2013;2013:659832. [PMID: 24804113 DOI: 10.1155/2013/659832] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Khoury P, Zagallo P, Talar-Williams C, Santos CS, Dinerman E, Holland NC, Klion AD. Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome. Allergy 2012;67:1149-56. [PMID: 22775568 DOI: 10.1111/j.1398-9995.2012.02873.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
69 Lefèvre G, Leurs A, Gibier JB, Copin MC, Staumont-Sallé D, Dezoteux F, Chenivesse C, Lopez B, Terriou L, Hachulla E, Launay D, Etienne N, Labalette M, DeGroote P, Pontana F, Quemeneur T, Hatron PY, Schleinitz N, Viallard JF, Hamidou M, Martin T, Morati-Hafsaoui C, Groh M, Lambert M, Kahn JE; CEREO—French National Reference Center for Hypereosinophilic Syndromes. "Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients. J Allergy Clin Immunol Pract 2020;8:1329-1340.e3. [PMID: 31863912 DOI: 10.1016/j.jaip.2019.12.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
70 Sun RR, Chen TZ, Meng M. Hypereosinophilic syndrome presenting as acute ischemic stroke, myocardial infarction, and arterial involvement: A case report. World J Clin Cases 2022; 10(11): 3547-3552 [DOI: 10.12998/wjcc.v10.i11.3547] [Reference Citation Analysis]
71 Yilmaz I, Kaynar L, Tutar N, Pala C, Canoz O, Buyukoglan H, Gulmez I. Response to imatinib in patient with corticosteroid-unresponsive idiopathic hypereosinophilic syndrome. Rev Port Pneumol (2006) 2016;22:59-60. [PMID: 26416165 DOI: 10.1016/j.rppnen.2015.08.003] [Reference Citation Analysis]
72 Busardò FP, Portelli F, Montana A, Rotolo MC, Pichini S, Maresi E. When a death apparently associated to sexual assault is instead a natural death due to idiopathic hypereosinophilic syndrome: The importance of gamma-hydroxybutyric acid analysis in vitreous humor. Legal Medicine 2017;26:92-7. [DOI: 10.1016/j.legalmed.2017.04.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
73 Lee D, Ahn T. Central nervous system involvement of hypereosinophilic syndrome: A report of 10 cases and a literature review. Journal of the Neurological Sciences 2014;347:281-7. [DOI: 10.1016/j.jns.2014.10.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
74 Kuang FL, Klion AD. Biologic Agents for the Treatment of Hypereosinophilic Syndromes. J Allergy Clin Immunol Pract 2017;5:1502-9. [PMID: 29122152 DOI: 10.1016/j.jaip.2017.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
75 Ladinsky HT, Elizalde A, Schickler R, Dees PB, Crenshaw ML, Sleasman JW. Hypereosinophilic syndrome and hemimelia in a patient with chromosome 6p22.3 deletion. Pediatr Allergy Immunol 2014;25:500-3. [PMID: 24628666 DOI: 10.1111/pai.12213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
76 Walker MM, Potter M, Talley NJ. Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus. The Lancet Gastroenterology & Hepatology 2018;3:271-80. [DOI: 10.1016/s2468-1253(18)30005-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
77 Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, Ruoppolo G, Altissimi G, De Vincentiis M. Churg-Strauss syndrome. Autoimmun Rev 2015;14:341-8. [PMID: 25500434 DOI: 10.1016/j.autrev.2014.12.004] [Cited by in Crossref: 152] [Cited by in F6Publishing: 113] [Article Influence: 19.0] [Reference Citation Analysis]
78 Chaudhary S, Bansal C, Ranga U, Singh K. Erythrodermic mycosis fungoides with hypereosinophilic syndrome: a rare presentation. Ecancermedicalscience 2013;7:337. [PMID: 23940492 DOI: 10.3332/ecancer.2013.337] [Reference Citation Analysis]
79 Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol 2012;49:149-59. [PMID: 22449625 DOI: 10.1053/j.seminhematol.2012.01.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
80 Yousefi S, Simon D, Simon H. Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease. Current Opinion in Immunology 2012;24:736-9. [DOI: 10.1016/j.coi.2012.08.010] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 7.8] [Reference Citation Analysis]
81 von Gunten S, Simon HU. Granulocyte death regulation by naturally occurring autoantibodies. Adv Exp Med Biol 2012;750:157-72. [PMID: 22903673 DOI: 10.1007/978-1-4614-3461-0_12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
82 Jorge I, Amaral B, Soares-Almeida LM, Foxall RB, Tendeiro R, Santos JM, Sousa AE, Victorino RM. Massive hypereosinophilia and vasculitis associated with major expansion of interleukin-5-producing CD8+ T cells in HIV-1 infection. AIDS 2014;28:1075-7. [PMID: 24685745 DOI: 10.1097/QAD.0000000000000205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
83 Liao W, Long H, Chang CC, Lu Q. The Eosinophil in Health and Disease: from Bench to Bedside and Back. Clin Rev Allergy Immunol 2016;50:125-39. [PMID: 26410377 DOI: 10.1007/s12016-015-8507-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
84 Radonjic-Hoesli S, Wang X, de Graauw E, Stoeckle C, Styp-Rekowska B, Hlushchuk R, Simon D, Spaeth PJ, Yousefi S, Simon HU. Adhesion-induced eosinophil cytolysis requires the receptor-interacting protein kinase 3 (RIPK3)-mixed lineage kinase-like (MLKL) signaling pathway, which is counterregulated by autophagy. J Allergy Clin Immunol 2017;140:1632-42. [PMID: 28412393 DOI: 10.1016/j.jaci.2017.01.044] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]
85 van Grotel M, de Hoog M, de Krijger R, Beverloo H, van den Heuvel-eibrink M. Hypereosinophilic syndrome in children. Leukemia Research 2012;36:1249-54. [DOI: 10.1016/j.leukres.2012.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
86 Singh AD, Suri TM, Jagdish RK, Kumar U. Unravelling the NERDS syndrome. BMJ Case Rep 2018;2018:bcr-2017-223506. [PMID: 29754136 DOI: 10.1136/bcr-2017-223506] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Kumar A, Haider A, Siddiqa A. Organ-Specific Hypereosinophilic Syndrome Presenting as Eosinophilic Gastroenteritis. Cureus 2021;13:e16021. [PMID: 34258128 DOI: 10.7759/cureus.16021] [Reference Citation Analysis]
88 Kahn JE, Groh M, Lefèvre G. (A Critical Appraisal of) Classification of Hypereosinophilic Disorders. Front Med (Lausanne) 2017;4:216. [PMID: 29259972 DOI: 10.3389/fmed.2017.00216] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
89 He YQ, Zhao YN, Zhu JM, Zhang MC, Liu L, Zeng H, Yang P. Imaging diagnosis for left ventricular thrombosis in idiopathic hypereosinophilic syndrome: two case reports. Medicine (Baltimore) 2014;93:e82. [PMID: 25275526 DOI: 10.1097/MD.0000000000000082] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
90 Stella S, Massimino M, Manzella L, Pennisi MS, Tirrò E, Romano C, Vitale SR, Puma A, Tomarchio C, Gregorio SD, Palumbo GA, Vigneri P. Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes. Int J Mol Sci 2021;22:E486. [PMID: 33418988 DOI: 10.3390/ijms22020486] [Reference Citation Analysis]
91 Fulkerson PC, Rothenberg ME. Eosinophil Development, Disease Involvement, and Therapeutic Suppression. Adv Immunol 2018;138:1-34. [PMID: 29731004 DOI: 10.1016/bs.ai.2018.03.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
92 Pal R, Yanamandra U, Kumar P, Banerjee N. Benign Subcutaneous Nodules and Hypereosinophilic Syndrome: A Rare Presentation of an Uncommon Entity. Case Rep Med 2019;2019:2387832. [PMID: 31827521 DOI: 10.1155/2019/2387832] [Reference Citation Analysis]
93 Izquierdo-domínguez A, Cordero Castillo A, Alobid I, Mullol J. Churg-Strauss Syndrome or Eosinophilic Granulomatosis with Polyangiitis. Sinusitis 2016;1:24-43. [DOI: 10.3390/sinusitis1010024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
94 Scanvion Q, Béné J, Gautier S, Grandvuillemin A, Le Beller C, Chenaf C, Etienne N, Brousseau S, Cortot AB, Mortier L, Staumont-Sallé D, Morschhauser F, Forestier A, Groh M, Launay D, Hachulla E, Labalette M, Kahn JE, Lefèvre G. Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database. Oncoimmunology 2020;9:1722022. [PMID: 32313716 DOI: 10.1080/2162402X.2020.1722022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
95 Klion AD. Eosinophilia: introduction. Semin Hematol 2012;49:111-2. [PMID: 22449620 DOI: 10.1053/j.seminhematol.2012.01.004] [Reference Citation Analysis]
96 Wang YB, Han YJ, Uchida K, Zhao BC, Chen KB, Ma WY, Xie FJ, Liu TL, Zhang LX. Pneumothorax as the initial manifestation of idiopathic hypereosinophilic syndrome. Ann Thorac Surg 2014;98:1838-41. [PMID: 25441802 DOI: 10.1016/j.athoracsur.2013.12.078] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Nishi R, Koike H, Ohyama K, Fukami Y, Ikeda S, Kawagashira Y, Iijima M, Katsuno M, Sobue G. Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA. Neurology 2020;94:e1726-37. [PMID: 32217776 DOI: 10.1212/WNL.0000000000009309] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
98 Curtis C, Ogbogu P. Hypereosinophilic Syndrome. Clinic Rev Allerg Immunol 2016;50:240-51. [DOI: 10.1007/s12016-015-8506-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
99 Freymond N, Kahn JE, Legrand F, Renneville A, Cordier JF, Cottin V. Clonal expansion of T cells in patients with eosinophilic lung disease. Allergy 2011;66:1506-8. [PMID: 21883280 DOI: 10.1111/j.1398-9995.2011.02697.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
100 Holle JU, Moosig F, Dalhoff K, Gross WL. Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides. Arthritis Res Ther 2011;13:224. [PMID: 21722330 DOI: 10.1186/ar3307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
101 Della-Torre E, Tresoldi M, Scotti R, Praderio L, Mellone R, Ponzoni M, Doglioni C, Sabbadini MG. Atypical presentation of Churg-Strauss syndrome or an undescribed hypereosinophilic disease? J Allergy Clin Immunol 2011;128:908-11. [PMID: 21872916 DOI: 10.1016/j.jaci.2011.07.052] [Reference Citation Analysis]
102 Hana CK, Caldera H. Hypereosinophilic Syndrome, Multiorgan Involvement and Response to Imatinib. Cureus 2020;12:e8493. [PMID: 32656011 DOI: 10.7759/cureus.8493] [Reference Citation Analysis]
103 Nair P, Ochkur SI, Protheroe C, Simms E, Lee NA, Lee JJ. The identification of eosinophilic gastroenteritis in prednisone-dependent eosinophilic bronchitis and asthma. Allergy Asthma Clin Immunol 2011;7:4. [PMID: 21362188 DOI: 10.1186/1710-1492-7-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
104 Li QF, Zhang Q, Huang YF, Zhang ZX. Acute progressive stroke with middle cerebral artery occlusion caused by idiopathic hypereosinophilic syndrome: a case report. BMC Neurol 2020;20:361. [PMID: 33003998 DOI: 10.1186/s12883-020-01941-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
105 Hur K, Kim SH, Kim JM. Potential Implications of Long Noncoding RNAs in Autoimmune Diseases. Immune Netw 2019;19:e4. [PMID: 30838159 DOI: 10.4110/in.2019.19.e4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 10.7] [Reference Citation Analysis]
106 Gurgun A, Tuluce K, Tuluce SY, Gurgun C, Bayraktaroglu S, Tombuloglu M, Cinar CS. Hypereosinophilic syndrome presenting with large left ventricular apical thrombus and pulmonary embolism. Echocardiography 2011;28:E180-2. [PMID: 21854430 DOI: 10.1111/j.1540-8175.2011.01479.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
107 Farahi N, Gillett D, Loutsios C, Peters AM, Summers C, Chilvers ER. Measurement of Eosinophil Kinetics In Vivo. Methods Mol Biol 2021;2241:183-91. [PMID: 33486737 DOI: 10.1007/978-1-0716-1095-4_15] [Reference Citation Analysis]
108 Vega Villanueva KL, Espinoza LR. Eosinophilic Vasculitis. Curr Rheumatol Rep 2020;22. [DOI: 10.1007/s11926-020-0881-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
109 Szczeklik W, Sanak M, Mastalerz L, Sokołowska BM, Gielicz A, Soja J, Kumik J, Musiał J, Szczeklik A. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome. Clin Exp Allergy 2012;42:513-22. [PMID: 22417211 DOI: 10.1111/j.1365-2222.2011.03943.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
110 Kotzin JJ, Spencer SP, McCright SJ, Kumar DBU, Collet MA, Mowel WK, Elliott EN, Uyar A, Makiya MA, Dunagin MC, Harman CCD, Virtue AT, Zhu S, Bailis W, Stein J, Hughes C, Raj A, Wherry EJ, Goff LA, Klion AD, Rinn JL, Williams A, Flavell RA, Henao-Mejia J. The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan. Nature 2016;537:239-43. [PMID: 27525555 DOI: 10.1038/nature19346] [Cited by in Crossref: 142] [Cited by in F6Publishing: 144] [Article Influence: 23.7] [Reference Citation Analysis]
111 Mattis DM, Wang SA, Lu CM. Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia. Am J Clin Pathol 2020;154:305-18. [PMID: 32525541 DOI: 10.1093/ajcp/aqaa056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
112 Kojima K, Maeda J, Mikami S, Yamagishi H, Ide H, Hattori S, Takahashi T, Awazu M. Eosinophilic cystitis presented as a manifestation of hypereosinophilic syndrome: a case report and review of the literature. Nephron Extra 2013;3:30-5. [PMID: 23573073 DOI: 10.1159/000346713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
113 Powell J, Kaur M, Muc R, Colloby P, Salim A. Persistent hypereosinophilia with Wells syndrome: Persistent hypereosinophilia with Wells syndrome. Clinical and Experimental Dermatology 2013;38:40-3. [DOI: 10.1111/j.1365-2230.2012.04370.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
114 Klion AD. How I treat hypereosinophilic syndromes. Blood 2015;126:1069-77. [PMID: 25964669 DOI: 10.1182/blood-2014-11-551614] [Cited by in Crossref: 99] [Cited by in F6Publishing: 77] [Article Influence: 14.1] [Reference Citation Analysis]
115 Wardlaw AJ, Wharin S, Aung H, Shaffu S, Siddiqui S. The causes of a peripheral blood eosinophilia in a secondary care setting. Clin Exp Allergy 2021;51:902-14. [PMID: 34080735 DOI: 10.1111/cea.13889] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
116 Vaisben E, Brand R, Kadakh A, Nassar F. The role of empirical albendazole treatment in idiopathic hypereosinophilia - a case series. Can J Infect Dis Med Microbiol 2015;26:323-4. [PMID: 26744590 DOI: 10.1155/2015/531675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
117 de Graauw E, Sitaru C, Horn M, Borradori L, Yousefi S, Simon HU, Simon D. Evidence for a role of eosinophils in blister formation in bullous pemphigoid. Allergy 2017;72:1105-13. [PMID: 28135772 DOI: 10.1111/all.13131] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 11.6] [Reference Citation Analysis]
118 Yadav D, Sharma A, Agarwal S, Gupta V. Hypereosinophilic dermatitis: generalised lichenification and gyrate erythema as the sole manifestation of idiopathic hypereosinophilic syndrome. BMJ Case Rep 2019;12:e232142. [PMID: 31619402 DOI: 10.1136/bcr-2019-232142] [Reference Citation Analysis]
119 Bhasi A, Patnaik I, Panda PK, Singh A. Hypereosinophilic syndrome presenting as eosinophilic gastroenteritis disorder and splinter hemorrhages: A case report. World J Gastrointest Pharmacol Ther 2022; 13(2): 23-29 [DOI: 10.4292/wjgpt.v13.i2.23] [Reference Citation Analysis]
120 Noel P. Eosinophilic myeloid disorders. Semin Hematol 2012;49:120-7. [PMID: 22449622 DOI: 10.1053/j.seminhematol.2012.01.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
121 Yılmaz İ, Kaynar L, Tutar N, Pala Ç, Canöz Ö, Yıldırım A, Büyükoğlan H, Gülmez İ. Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib. Turk Thorac J 2016;17:118-21. [PMID: 29404138 DOI: 10.5578/ttj.30508] [Reference Citation Analysis]
122 Mäder P, Kattner L. Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry. J Med Chem 2020;63:14243-75. [DOI: 10.1021/acs.jmedchem.0c00960] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 14.5] [Reference Citation Analysis]
123 Tavil B, Aytaç S, Unal S, Kuskonmaz B, Gumruk F, Cetin M. Hypereosinophilic Syndrome: Hacettepe Experience. J Pediatr Hematol Oncol 2016;38:539-43. [PMID: 27548336 DOI: 10.1097/MPH.0000000000000668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
124 Radonjic-Hoesli S, Brüggen MC, Feldmeyer L, Simon HU, Simon D. Eosinophils in skin diseases. Semin Immunopathol 2021;43:393-409. [PMID: 34097126 DOI: 10.1007/s00281-021-00868-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Wicklein D, Schmidt A, Labitzky V, Ullrich S, Valent P, Schumacher U. E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model. PLoS One 2013;8:e70139. [PMID: 23922938 DOI: 10.1371/journal.pone.0070139] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
126 Baandrup U. Eosinophilic myocarditis. Herz 2012;37:849-53. [DOI: 10.1007/s00059-012-3701-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
127 Barry J, Gadre A, Akuthota P. Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases. Curr Opin Immunol 2020;66:129-35. [PMID: 33166785 DOI: 10.1016/j.coi.2020.10.005] [Reference Citation Analysis]
128 Wicklein D, Ramos Leal N, Salamon J, Thamer M, Herrmann H, Valent P, Schumacher U, Ullrich S. Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model. PLoS One 2012;7:e30567. [PMID: 22348015 DOI: 10.1371/journal.pone.0030567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
129 Butterfield JH, Weiler CR. Use of pegylated interferon in hypereosinophilic syndrome. Leukemia Research 2012;36:192-7. [DOI: 10.1016/j.leukres.2011.09.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
130 Ishida T, Murayama T, Kobayashi S. Pneumonia and seizures due to hypereosinophilic syndrome—organ damage and eosinophilia without synchronisation: A case report. World J Clin Cases 2022; 10(18): 6325-6332 [DOI: 10.12998/wjcc.v10.i18.6325] [Reference Citation Analysis]
131 Santos YA, Silva BR, Lira PN, Vaz LC, Mafort TT, Bruno LP, Lopes AJ. Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes. Respir Med Case Rep 2017;21:1-6. [PMID: 28337408 DOI: 10.1016/j.rmcr.2017.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
132 Chen YY, Khoury P, Ware JM, Holland-Thomas NC, Stoddard JL, Gurprasad S, Waldner AJ, Klion AD. Marked and persistent eosinophilia in the absence of clinical manifestations. J Allergy Clin Immunol 2014;133:1195-202. [PMID: 23987798 DOI: 10.1016/j.jaci.2013.06.037] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
133 Prussin C. Eosinophilic gastroenteritis and related eosinophilic disorders. Gastroenterol Clin North Am. 2014;43:317-327. [PMID: 24813518 DOI: 10.1016/j.gtc.2014.02.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
134 Chen H, Raza HK, Jing J, Shen D, Xu P, Zhou S, Zu J, Yang X, Zhang W, Zhang S, Hua F, Cui G. Hypereosinophilic syndrome with central nervous system involvement: Two case reports and literature review. Brain Inj 2017;31:1695-700. [PMID: 28945486 DOI: 10.1080/02699052.2017.1357835] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
135 Just J, Bourgoin M, Amat F, Cottel N, Lambert N, Wanin S. Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab. ERJ Open Res 2020;6:00339-2020. [PMID: 33447610 DOI: 10.1183/23120541.00339-2020] [Reference Citation Analysis]
136 Nayak VH, Engin NY, Burns JJ, Ameta P. Hypereosinophilic Syndrome With Eosinophilic Gastritis. Glob Pediatr Health 2017;4:2333794X17705239. [PMID: 28491930 DOI: 10.1177/2333794X17705239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
137 Minupuri A, Ramireddy K, Patel R, Hossain S, Salas Noain J. Hyper-Eosinophilic Syndrome Masquerading as Myocardial Infarction, Stroke and Cancer. Cureus 2020;12:e9630. [PMID: 32923231 DOI: 10.7759/cureus.9630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Valent P, Degenfeld-Schonburg L, Sadovnik I, Horny HP, Arock M, Simon HU, Reiter A, Bochner BS. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity. Semin Immunopathol 2021;43:423-38. [PMID: 34052871 DOI: 10.1007/s00281-021-00863-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Biedermann L, Straumann A, Greuter T, Schreiner P. Eosinophilic esophagitis-established facts and new horizons. Semin Immunopathol 2021;43:319-35. [PMID: 34097125 DOI: 10.1007/s00281-021-00855-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Lee J, Dierkhising R, Wu TT, Alexander J, Weiler C. Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic. Dig Dis Sci. 2011;56:3254-3261. [PMID: 21655949 DOI: 10.1007/s10620-011-1754-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
141 Das JK, Gupta K, Deshmukh S, Shrivastava R. A rare case of hypereosinophilic syndrome presenting with unilateral proptosis and torticollis. Indian J Ophthalmol 2018;66:1508-11. [PMID: 30249857 DOI: 10.4103/ijo.IJO_316_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Khallaayoune M, Sialiti S, Meziane M, Senouci K. Bullous pemphigoid-like rash revealing hypereosinophilic syndrome. BMJ Case Rep 2021;14:e242695. [PMID: 34103306 DOI: 10.1136/bcr-2021-242695] [Reference Citation Analysis]
143 Choi CB, Park YB, Lee SW. Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients. Yonsei Med J 2019;60:705-12. [PMID: 31347324 DOI: 10.3349/ymj.2019.60.8.705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
144 Plötz SG, Hüttig B, Aigner B, Merkel C, Brockow K, Akdis C, Darsow U, Ring J. Clinical overview of cutaneous features in hypereosinophilic syndrome. Curr Allergy Asthma Rep 2012;12:85-98. [PMID: 22359067 DOI: 10.1007/s11882-012-0241-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
145 Mahajan VK, Singh R, Mehta KS, Chauhan PS, Sharma S, Gupta M, Rawat R. Idiopathic hypereosinophilic syndrome: a rare cause of erythroderma. J Dermatol Case Rep 2014;8:108-14. [PMID: 25621091 DOI: 10.3315/jdcr.2014.1185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
146 Egan M, Furuta GT. Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis. Ann Allergy Asthma Immunol 2018;121:162-7. [PMID: 29940308 DOI: 10.1016/j.anai.2018.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
147 Engwenyu LR, Tchakarov A, Zhao B. Eosinophilic granulomatosis with polyangiitis in a continuous flow left ventricular assist device patient: a case report and review of literature. Cardiovascular Pathology 2019;39:70-3. [DOI: 10.1016/j.carpath.2018.12.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
148 Kim JS, Park S, Kim HK, Jeon YS, Min SK, Hwang HY. Massive thromboembolism owing to the left ventricular thrombus associated with the hypereosinophilic syndrome. Korean J Thorac Cardiovasc Surg 2014;47:478-82. [PMID: 25346905 DOI: 10.5090/kjtcs.2014.47.5.478] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
149 Lee LY, Hew GSY, Mehta M, Shukla SD, Satija S, Khurana N, Anand K, Dureja H, Singh SK, Mishra V, Singh PK, Gulati M, Prasher P, Aljabali AAA, Tambuwala MM, Thangavelu L, Panneerselvam J, Gupta G, Zacconi FC, Shastri M, Jha NK, Xenaki D, MacLoughlin R, Oliver BG, Chellappan DK, Dua K. Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. Life Sci 2021;267:118973. [PMID: 33400932 DOI: 10.1016/j.lfs.2020.118973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
150 Wu P, Chen Y, Zhang H, Li C. Idiopathic hypereosinophilic syndrome presenting with multiple organ damage: A case report. Medicine (Baltimore) 2019;98:e14532. [PMID: 30855439 DOI: 10.1097/MD.0000000000014532] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
151 Rosenberg CE, Khoury P. Approach to Eosinophilia Presenting With Pulmonary Symptoms. Chest 2021;159:507-16. [PMID: 33002503 DOI: 10.1016/j.chest.2020.09.247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
152 Helbig G. Advances in the diagnosis and treatment of eosinophilia: . Current Opinion in Hematology 2014;21:3-7. [DOI: 10.1097/moh.0000000000000011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Maric I, Sun X. Advances in diagnosis of mastocytosis and hypereosinophilic syndrome. Semin Hematol 2019;56:22-9. [PMID: 30573041 DOI: 10.1053/j.seminhematol.2018.05.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
154 Germic N, Hosseini A, Yousefi S, Karaulov A, Simon HU. Regulation of eosinophil functions by autophagy. Semin Immunopathol 2021;43:347-62. [PMID: 34019141 DOI: 10.1007/s00281-021-00860-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
155 Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat Rev Drug Discov 2013;12:117-29. [PMID: 23334207 DOI: 10.1038/nrd3838] [Cited by in Crossref: 249] [Cited by in F6Publishing: 231] [Article Influence: 27.7] [Reference Citation Analysis]
156 Khwaja GA, Duggal A, Kulkarni A, Choudhary N, Gupta M, Chowdhury D, Bohra V, Zutshi D. Hypereosinophilia-an unusual cause of multiple embolic strokes and multi-organ dysfunction. J Clin Diagn Res 2013;7:2316-8. [PMID: 24298517 DOI: 10.7860/JCDR/2013/6004.3512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
157 Curtis C, Ogbogu PU. Evaluation and Differential Diagnosis of Persistent Marked Eosinophilia. Immunol Allergy Clin North Am 2015;35:387-402. [PMID: 26209891 DOI: 10.1016/j.iac.2015.04.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
158 Gioffredi A, Maritati F, Oliva E, Buzio C. Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol 2014;5:549. [PMID: 25404930 DOI: 10.3389/fimmu.2014.00549] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
159 Butterfield JH, Kane GC, Weiler CR. Hypereosinophilic syndrome: endomyocardial biopsy versus echocardiography to diagnose cardiac involvement. Postgrad Med 2017;129:517-23. [PMID: 28440714 DOI: 10.1080/00325481.2017.1317215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
160 Madden VR, Schoeffler GL. Idiopathic hypereosinophilic syndrome resulting in distal aortic thromboembolism in a dog: Idiopathic hypereosinophilia and thromboembolism. Journal of Veterinary Emergency and Critical Care 2016;26:819-24. [DOI: 10.1111/vec.12545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Klion AD. Eosinophilia: a pragmatic approach to diagnosis and treatment. Hematology 2015;2015:92-7. [DOI: 10.1182/asheducation-2015.1.92] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
162 Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130:607-612.e9. [PMID: 22460074 DOI: 10.1016/j.jaci.2012.02.019] [Cited by in Crossref: 350] [Cited by in F6Publishing: 270] [Article Influence: 35.0] [Reference Citation Analysis]
163 Mahr A, Moosig F, Neumann T, Szczeklik W, Taillé C, Vaglio A, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): evolutions in classification, etiopathogenesis, assessment and management. Curr Opin Rheumatol 2014;26:16-23. [PMID: 24257370 DOI: 10.1097/BOR.0000000000000015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
164 Häcker H, Chi L, Rehg JE, Redecke V. NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation. J Immunol 2012;188:4602-10. [PMID: 22474019 DOI: 10.4049/jimmunol.1200021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]